Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Agios Pharmaceuticals (AGIO) Long-Term Deferred Tax: 2012-2013

  • Agios Pharmaceuticals' Long-Term Deferred Tax was N/A to $2.7 million in Q3 2013 from the same period last year, while for Sep 2013 it was $2.7 million, marking a year-over-year change of. This contributed to the annual value of $2.7 million for FY2012, which is N/A change from last year.
  • As of Q3 2013, Agios Pharmaceuticals' Long-Term Deferred Tax stood at $2.7 million, which was down 0.00% from $2.7 million recorded in Q2 2013.
  • Over the past 5 years, Agios Pharmaceuticals' Long-Term Deferred Tax peaked at $2.7 million during Q4 2012, and registered a low of $2.7 million during Q4 2012.
  • Its 2-year average for Long-Term Deferred Tax is $2.7 million, with a median of $2.7 million in 2013.